+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Characterization of kinase inhibitors using different phosphorylation states of colony stimulating factor-1 receptor tyrosine kinase



Characterization of kinase inhibitors using different phosphorylation states of colony stimulating factor-1 receptor tyrosine kinase



Journal of Biochemistry 151(1): 47-55



It is known that some kinase inhibitors are sensitive to the phosphorylation state of the kinase, and therefore those compounds can discriminate between a phosphorylated and unphosphorylated protein. In this study, we prepared two colony stimulating factor-1 receptor (CSF-1R) tyrosine kinase proteins: one highly phosphorylated by autophosphorylation and the other dephosphorylated by phosphatase treatment. These kinases were subjected to an activity-based assay to investigate the effect of their phosphorylation state on the potency of several kinase inhibitors. Dasatinib, sorafenib, PD173074 and staurosporine showed similar inhibition against different phosphorylation states of CSF-1R, but pazopanib, sunitinib, GW2580 and imatinib showed more potent inhibition against dephosphorylated CSF-1R. Binding analysis of the inhibitors to the two different phosphorylation forms of CSF-1R, using surface plasmon resonance spectrometry, revealed that staurosporine bound to both forms with similar affinity, but sunitinib bound to the dephosphorylated form with higher affinity. Thus, these observations suggest that sunitinib binds preferentially to the inactive form, preventing the activation of CSF-1R. Screening against different activation states of kinases should be an important approach for prioritizing compounds and should facilitate inhibitor design.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036297880

Download citation: RISBibTeXText

PMID: 21880693

DOI: 10.1093/jb/mvr112


Related references

Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors. Molecular Cancer Therapeutics 5(4): 1007-1013, 2006

Tyrosine phosphorylation of MAP kinase, but not ribosomal S6 kinase II, by granulocyte-macrophage colony-stimulating factor. Journal of Leukocyte Biology 0(Suppl. 3): 33, 1992

JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia. Molecular Cancer Therapeutics 8(11): 3151-3161, 2009

Crystal structure of the tyrosine kinase domain of colony-stimulating factor-1 receptor (cFMS) in complex with two inhibitors. Journal of Biological Chemistry 282(6): 4094-4101, 2007

A point mutation at tyrosine 809 in the human colony stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity association with phosphatidylinositol 3 kinase or induction of c fos and junb genes. Proceedings of the National Academy of Sciences of the United States of America 87(17): 6738-6742, 1990

Progenipoietins: Biological characterization of a family of dual agonists of fetal liver tyrosine kinase-3 and the granulocyte colony-stimulating factor receptor. Experimental Hematology 29(1): 41-50, 2001

Tyrosine 706 and tyrosine 807 phosphorylation site mutants in the murine colony stimulating factor 1 receptor are unaffected in their ability to bind or phosphorylate phosphatidylinositol 3 kinase but show differential defects in their ability to induce early response gene transcription. Molecular & Cellular Biology 11(9): 4698-4709, 1991

The related adhesion focal tyrosine kinase (RAFTK) is tyrosine phosphorylated and participates in colony-stimulating factor-1/macrophage colony-stimulating factor signaling in monocyte-macrophages. Blood 91(10): 3967-3973, 1998

Development of a quantitative, high-throughput cell-based enzyme-linked immunosorbent assay for detection of colony-stimulating factor-1 receptor tyrosine kinase inhibitors. Journal of Biochemical and Biophysical Methods 60(1): 69-79, 2004

Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proceedings of the National Academy of Sciences of the United States of America 91(8): 2985-2988, 1994

Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase. Blood 79(11): 2880-2887, 1992

Purification of the colony-stimulating factor 1 receptor and demonstration of its tyrosine kinase activity. Proceedings of the National Academy of Sciences of the United States of America 84(5): 1268-1271, 1987

Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors. Journal of Medicinal Chemistry 61(13): 5450-5466, 2018

Tyrosine kinase inhibitors 16 6,5,6-tricyclic benzothieno pyrimidines and pyrimido - and - indoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase. Journal of Medicinal Chemistry 42(26): 5464-5474, 1999

Tyrosine kinase inhibitors. 16. 6,5,6-tricyclic benzothieno[3, 2-d]pyrimidines and pyrimido[5,4-b-] and -[4,5-b]ĭndoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase. Journal of Medicinal Chemistry 42(26): 5464-5474, 1999